Crystal structure of a T325I/T329I/H333Y/H335Q mutant of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI-IIYQ)

Crystal structure of a T325I/T329I/H333Y/H335Q mutant of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI-IIYQ) Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, ARGININE, Carboxypeptidase B2, ... Authors: Brondijk, T.H.C, Huizinga, E.G. Deposit date: 2008-05-19 Release date: 2008-07-01 Last modified: 2024-11-13 Method: X-RAY DIFFRACTION (2.8 Å) Cite: Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation Blood, 112, 2008